Related Experiment Video
Updated: May 9, 2025

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
AI interventions in cancer screening: balancing equity and cost-effectiveness
Cristina Roadevin1, Harry Hill2
1School of Medicine, University of Nottingham, Nottingham, England, UK.
Artificial intelligence (AI) in cancer screening can improve accuracy and efficiency. However, AI must prioritize non-attenders to reduce health disparities and ensure equitable outcomes for all populations.
Area of Science:
- Health Services Research
- Artificial Intelligence
- Public Health
Background:
- Artificial intelligence (AI) offers potential benefits for cancer screening, including enhanced diagnostic accuracy and cost-effectiveness.
- Current AI implementations in screening often neglect non-attenders, widening existing health disparities.
- Underserved populations face worse cancer outcomes due to barriers in accessing screening programs.
Purpose of the Study:
- To analyze the equity challenges and resource allocation implications of integrating AI into cancer screening.
- To advocate for AI interventions that prioritize non-attenders and address health inequities.
- To propose methods for identifying and evaluating cost-saving AI interventions for equitable healthcare delivery.
Main Methods:
- Case study using breast cancer screening programs.
- Advocacy for cost-saving AI intervention design and implementation.
- Utilizing decision modeling to identify and evaluate interventions.
- Recommending distributional cost-effectiveness analysis to quantify disparities.
Main Results:
- AI in screening currently favors existing attendees, exacerbating inequities.
- Prioritizing non-attenders in AI interventions is crucial for reducing disparities.
- Cost-saving AI interventions can fund strategies to increase engagement among non-attenders.
- Transparency in AI investment decisions is needed to account for equity and opportunity costs.
Conclusions:
- AI integration in cancer screening must balance technological advancement with the ethical imperative for equitable health outcomes.
- Policymakers should explicitly consider equity implications and opportunity costs of AI investments.
- Implementing AI with a focus on non-attenders and underserved populations is essential for reducing cancer outcome disparities.
Related Concept Videos
Preventive Healthcare Services
Cancer Survival Analysis
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...

